MIAMI--(BUSINESS WIRE)--A report by Heru Inc., the innovative vision diagnostics and augmentation leader, indicates that visual field test results from its wearable platform, re:Vive by Heru, are ...

Please provide your email address to receive an email when new articles are posted on . A vital part of glaucoma management is assessing patients for the possibility of progressive disease.

Please provide your email address to receive an email when new articles are posted on . Visual field mean deviation and threshold values found with Heru’s automated visual field testing platform ...

Figure 1. Humphrey visual field (HVF) testing, multifocal electroretinogram (mfERG), and fundus autofluorescence (FAF) clinical tests helped diagnose a case of multiple evanescent white dot syndrome.

The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.